Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0046 | 1 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |